Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The zinc-finger antiviral protein (ZAP) is a restriction factor that inhibits the replication of RNA and DNA viruses by binding to viral RNA rich in CpG dinucleotides. It promotes the degradation of viral RNA and inhibits translation, often synergizing with other immune pathways. ZAP interacts with cofactors like TRIM25 and KHNYN to enhance its antiviral activity. This protein is involved in the innate immune response, specifically targeting viral RNA for degradation and inhibiting its translation, making it a potential therapeutic target for antiviral strategies.
RNA degradation, Translation inhibition, Protein ubiquitination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-finger antiviral protein (ZAP).